Otros idiomas Vivos Therapeutics, Inc.

Acciones

VVOS

US92859E2072

Mercado cerrado - Nasdaq Otros sitios de cotización 22:30:01 13/05/2024			Varia. Cinco días.	Varia. 1 de enero.
2,01 ^USD	-5,41 %		-15,55 %	-83,84 %

01/04	Las señales de suavización de la inflación impulsan las estrechas ganancias de los futuros de renta variable de EE.UU. antes de la apertura del mercado	MT
01/04	Top Premarket Decliners	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Vivos Therapeutics : Material Event - Form 8-K	06/05
Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices	09/04
Vivos Therapeutics : rsquo; Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement	09/04
Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures	01/04
Top Premarket Decliners	01/04
Vivos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Earnings Flash (VVOS) VIVOS THERAPEUTICS Posts Q4 Revenue $3.2M	28/03
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update	28/03
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call	28/03
Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds	15/02
Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions	12/02
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities	06/02
Vivos Therapeutics, Inc. Receives FDA Clearance to Vivos Care Oral Appliances to Treat Severe OSA in Adults	06/02
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA	08/01
Vivos Therapeutics, Inc. Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA	08/01
Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”	11/12
Top Premarket Decliners	30/11
Health Care Drops Amid Skepticism About Cigna, Humana Deal -- Health Care Roundup	29/11
Sector Update: Health Care Stocks Mixed Late Afternoon	29/11
Top Midday Gainers	29/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Vivos Therapeutics, Inc.

Acciones

VVOS

US92859E2072

Otros idiomas

Filtros